April 6 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS ANNOUNCES POSITIVE RESULTS IN
DOSE-FINDING
PEDIATRIC STUDY OF MACIMORELIN
* AETERNA ZENTARIS-RESULTS GIVE CLINICAL FRAMEWORK TO
ADVANCE CO'S
PEDIATRIC INVESTIGATION PLAN FOR MACIMORELIN AS GROWTH HORMONE
DEFICIENCY DIAGNOSTIC
* AETERNA ZENTARIS INC - PEDIATRIC PK/PD PROFILE OF
MACIMORELIN
PROVED TO BE IN EXPECTED RANGE AND GENERALLY COMPARABLE TO DATA
IN ADULTS
* AETERNA ZENTARIS INC - PLANNED SAFETY AND EFFICACY STUDY
P02
EXPECTED TO COMMENCE IN Q4 2020
Source text for Eikon: ID:nGNX5Sr74C
Further company coverage: AEZS.TO
(((Reuters.Briefs@thomsonreuters.com);))